Evidence map›Paper›PMID 22232211›Full record

ArticleThe Journal of clinical investigation2012

Mutations in the ER-shaping protein reticulon 2 cause the axon-degenerative disorder hereditary spastic paraplegia type 12.

Gladys Montenegro, Adriana P Rebelo, James Connell, Rachel Allison, Carla Babalini, Michela D'Aloia, Pasqua Montieri, Rebecca Schüle, Hiroyuki Ishiura, Justin Price and 15 more

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed, 1 pooled it
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 1 synthesis or guideline pooled it, 169 citations in OpenAlex.

  1. Pooled it
  2. Inhibition of TFG function causes hereditary axon degeneration by impairing endoplasmic reticulum structure.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Trial
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 8 institutions in 6 countries.

Gladys MontenegroDepartment of Human Genetics, University of Miami Miller School of Medicine, Miami, Florida, USA.
Adriana P Rebelo
James Connell
Rachel Allison
Carla Babalini
Michela D'Aloia
Pasqua Montieri
Rebecca Schüle
Hiroyuki Ishiura
Justin Price
Alleene Strickland
Michael A Gonzalez
Lisa Baumbach-Reardon
Tine Deconinck
Jia Huang
Giorgio Bernardi
Jeffery M Vance
Mark T Rogers
Shoji Tsuji
Peter De Jonghe
Margaret A Pericak-Vance
Ludger Schöls
Antonio Orlacchio
Evan Reid
Stephan Züchner
University of Miami · USFondazione Santa Lucia · ITUniversity of Cambridge · GBGerman Center for Neurodegenerative Diseases · DEThe University of Tokyo · JPUniversity of Antwerp · BEUniversity of Rome Tor Vergata · ITUniversity Hospital of Wales · GB

Funding

GENOME STUDIES IN HEREDITARY SPASTIC PARAPLEGIA - beyond the exomeR01NS072248 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Stephan Zuchner · 2011 to 2026
$9.2M
Molecular And Genetic Analysis Of Autosomal Dominant Spastic ParaplegiaR01NS054132 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ZUCHNER, STEPHAN · 2008 to 2011
$1.3M
NINDS NIH HHS R01 NS054132NINDS NIH HHS R01NS054132NINDS NIH HHS R01 NS072248NINDS NIH HHS R01NS072248Telethon GGP10121Wellcome Trust 079895Wellcome Trust 082381
6 · The paper itself

Abstract

Hereditary spastic paraplegias (HSPs) are a group of genetically heterogeneous neurodegenerative conditions. They are characterized by progressive spastic paralysis of the legs as a result of selective, length-dependent degeneration of the axons of the corticospinal tract. Mutations in 3 genes encoding proteins that work together to shape the ER into sheets and tubules - receptor accessory protein 1 (REEP1), atlastin-1 (ATL1), and spastin (SPAST) - have been found to underlie many cases of HSP in Northern Europe and North America. Applying Sanger and exome sequencing, we have now identified 3 mutations in reticulon 2 (RTN2), which encodes a member of the reticulon family of prototypic ER-shaping proteins, in families with spastic paraplegia 12 (SPG12). These autosomal dominant mutations included a complete deletion of RTN2 and a frameshift mutation predicted to produce a highly truncated protein. Wild-type reticulon 2, but not the truncated protein potentially encoded by the frameshift allele, localized to the ER. RTN2 interacted with spastin, and this interaction required a hydrophobic region in spastin that is involved in ER localization and that is predicted to form a curvature-inducing/sensing hairpin loop domain. Our results directly implicate a reticulon protein in axonopathy, show that this protein participates in a network of interactions among HSP proteins involved in ER shaping, and further support the hypothesis that abnormal ER morphogenesis is a pathogenic mechanism in HSP.

Indexed as

MutationAdenosine TriphosphatasesDNA Mutational AnalysisEndoplasmic ReticulumHEK293 CellsHeLa CellsHumansMembrane ProteinsMuscle ProteinsNerve Tissue ProteinsSpastic Paraplegia, HereditarySpastinAdenosine TriphosphatasesMembrane ProteinsMuscle ProteinsNerve Tissue ProteinsRTN2 protein, humanSpastinSPAST protein, human

Identifiers

PMID22232211
PMCPMC3266795
OpenAlexW2043714441

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.